Economic burden of cancer does not stop after treatment
the ONA take:
According to a new study released online and being presented at the upcoming ASCO Annual Meeting in Chicago, IL, researchers have found that the economic burden of cancer extends into survivorship.
Specifically, cancer survivors deal with excess medical expenses, employment disability, and reduced production at work.
For the study, researchers analyzed the economic burden among elderly and nonelderly survivors with breast, colorectal, and prostate cancer in the United States using data from the Medical Expenditure Panel Survey between 2008 and 2012.
Researchers identified 1,568 female breast cancer survivors, 540 colorectal cancer survivors, and 1,170 prostate cancer survivors and compared their expenditures, productivity loss at work, and productivity loss at home to 100,000 people without a cancer history.
Results showed that elderly and nonelderly patients had between $9,278 and $20,238 of total annual economic burden depending on cancer type.
Nonelderly survivors of breast and colorectal cancer lost 3 and 7 days worth of productivity at work, respectively, and 3 and 5 days worth of productivity at home, respectively.
The economic burden of cancer extends into survivorship
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|